MedTrace Logo

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

NCT06960798 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-02

No results posted yet for this study

Summary

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Conditions

Interventions

OTHER

Bio-specimen Collection

Tissue samples will be taken from existing archived collections and sent for further analysis.

OTHER

Blood Draw

Blood samples will be collected within the first year of enrollment.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Adanma Ayanambakkam, MD · University of Oklahoma

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-02
Primary Completion
2028-05-30
Completion
2029-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06960798 on ClinicalTrials.gov